Stay Current Sign Up For Our Newsletter New cases and investigations, settlement deadlines, and news straight to your inbox
These properties make them an attractive therapeutic option for managing non-alcoholic fatty liver disease (NAFLD), particularly in individuals with concurrent diabetes mellitus and obesity
Thats the fat that accumulates around our abdomen, that invades our liver, into our pancreas, that gets into layers of our heart
Rather than assuming one approach works universally, precision medicine frameworks consider your metabolic biomarkers and genetic predispositions to GLP-1 response
Rashmi Advani, director of bariatric endoscopy at Mount Sinais Center for Interventional Endoscopy and an assistant professor of medicine at the Icahn School of Medicine, said GLP-1 medications address one barrier to patients considering bariatric surgery or bariatric endoscopy access to health care facilities that provide this type of care
2023;13(4)e23.00506